Three basic renal fxns
filtration, reabsorption, secretion
-reabsorb substances that body needs, maintain acid-base balance, excrete waste and foreign products
NaCl movement will result in
water movement- osmotic equilibrium
-increasing or decreasing Na+ reabsorption the kidney increases or decreases body fluid volume
Diuretic drugs act by
blocking sodium and chloride reabsorption to inc osmotic pressure in tubules, which prevent osmotic reabsorption of water and increases urine volume
Drugs acting early (loop diuretics) will produce
greatest diuresis
Drugs acting late (potassium sparing diuretics) result in
weaker diuresis
Clinical apps for diuretics
heart failure (loop diuretics), htn (thiazide diuretics), acute/chronic renal failure, nephrotic syndrome, cirrhosis
Acetazolamide
Carbonic Anhydrase inhibitors
Act on proximal convuluted tubule
-Oral and opthalmic preparations available
Toxicities: hyperchloremic metabolic acidosis, alkalinizing urine can cause calcium phosphate salts. can cause renal potassium wasting because more Na reaches collecting duct, more K is secreted
Sodium Glucose Cotransporter 2 (SGLT2) inhibitors
Not diuretics!
Loop diuretics
Furosemide, butanemide, torsemide, ethacyrnic acid (not sulfonamide derivative)
Hypokalemia caused by loop diuretics
Inc delivery of Na to distal convoluted tubule–> enhances K and H secretion
Loop diuretics and renin release
Reduced NaCl reabsorption– more Na in tubular fluid–> reduced NaCl influx into macula densa –> inc secretion of prostaglandins–> increased renin secretion (from juxtaglomerular cell)
Clinical use of loop diuretics
Loop diuretics AE
Thiazide and Thiazide like diuretics
Thiazide like drugs
-Chlorthalidone, indapamide, metolazone, guinethazone
Clinical uses for thiazides
AE for thiazides
hyperuricemia, hypokalemic metabolic alkalosis, hyperglycemia, hyperlipidemia, hyponatremia
Potassium sparing diuretics
K sparing diuretics clinical uses
-used for chf, primary mineralocorticoid hypersecretion (ACTH), secondary aldosteronism
aldosterone antagonists
Na channel blockers
Potassium sparing duretics toxicity
-hyperkalemia, hyperchloremic metabolic acidosis (H secretion reduced), gynecomastia (spironolactone), kidney stones with triamterene
Vaptans: ADH antagonists